Skip Navigation


Bioinformatics Advance Access originally published online on September 5, 2007
Bioinformatics 2007 23(20):2678-2685; doi:10.1093/bioinformatics/btm431
This Article
Right arrow Full Text
Right arrow Full Text (Print PDF)
Right arrow Supplementary data
Right arrow All Versions of this Article:
23/20/2678    most recent
btm431v3
btm431v2
btm431v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hetényi, C.
Right arrow Articles by Karelson, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hetényi, C.
Right arrow Articles by Karelson, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Structure-based calculation of drug efficiency indices

Csaba Hetényi 1,2,*, Uko Maran 1, Alfonso T. García-Sosa 1 and Mati Karelson 1

1Institute of Chemical Physics, University of Tartu, 2 Jakobi Street, 51014 Tartu, Estonia and 2Department of Organic Chemistry, Faculty of Pharmacy, Semmelweis University, Budapest, Hungary

*To whom correspondence should be addressed.


   Abstract

Motivation: The efficiency indices (EI's) have been derived from the experimental binding affinities of drug candidates to macromolecules. These ‘two-in-one’ measures include information on both pharmacodynamics and pharmacokinetics of the candidate molecules. The time-consuming experimental measurement of binding affinities of extensive molecule libraries may become a bottle-neck of large scale generation and application of EI's.

Results: To overcome this limitation, structure-based calculation of new EI's is introduced using the modified free energy function of the popular program package AutoDock. The results are validated on experimental binding data of biochemical systems such as potent inhibitors bound to ß-secretase, a key enzyme of Alzheimer's disease and various drug–protein complexes. Application of new EI's is tested. Thermodynamics of EI's and their role in virtual high - throughput screening of drugs and in the development of docking programs are discussed.

Contact: csabahete{at}yahoo.com

Supplementary information: Accompanies this manuscript on the publisher's web site.

Associate Editor: Anna Tramontano


Received on March 17, 2007; revised on August 6, 2007; accepted on August 18, 2007

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.